| 摘要: |
| 结合日常临床试验管理工作实践,本文探讨了抗新型冠状病毒药物临床试验质量管理,阐述质量保证的体系构成和质量控制的实施要点,总结目前抗新型冠状病毒药物临床试验质量面临的问题并提出建议。 |
| 关键词: 抗新型冠状病毒药物临床试验 质量管理 质量保证 质量控制 |
| DOI:10.13506/j.cnki.jpr.2023.07.007 |
| 基金项目:国家重点研发计划项目(No.2022YFC0868600) |
|
出版日期:2023-07-25
|
|
| The quality management of clinical trials of antiviral drugs against SARS-CoV-2 |
| JIANG Bo1,2,WANG Bailu1,2 |
| (1.Qilu Hospital of Shandong University Clinical Trial Center, Jinan 250000, China; 2.NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drugs,Jinan 250000, China) |
| Abstract: |
| Combined with the practice of clinical trial management, this article analyzed the quality management of clinical trials of antiviral drugs against SARS-CoV-2, described the organizational structure of quality assurance and the key points of quality control, summarized the quality problems of clinical trials of antiviral drugs against SARS-CoV-2, and proposed the improvement measures. |
| Key words: Clinical trials of antiviral drugs against SARS-CoV-2 Quality management Quality assurance Quality control |